SETH LERNER to Prostate-Specific Antigen
This is a "connection" page, showing publications SETH LERNER has written about Prostate-Specific Antigen.
Connection Strength
0.368
-
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide. Eur Urol Oncol. 2024 Oct; 7(5):1097-1104.
Score: 0.211
-
Positive margins after radical prostatectomy: implications for failure and role of adjuvant treatment. Urol Oncol. 2013 Jul; 31(5):531-41.
Score: 0.088
-
Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer. JAMA Netw Open. 2024 Oct 01; 7(10):e2437871.
Score: 0.055
-
Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res. 2006 Aug 15; 12(16):4872-5.
Score: 0.016